Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.2%

23 terminated/withdrawn out of 548 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

23%

124 trials in Phase 3/4

Results Transparency

9%

26 of 276 completed trials have results

Key Signals

64 recruiting26 with results21 terminated

Enrollment Performance

Analytics

N/A
198(50.9%)
Phase 4
85(21.9%)
Phase 2
52(13.4%)
Phase 3
39(10.0%)
Phase 1
15(3.9%)
389Total
N/A(198)
Phase 4(85)
Phase 2(52)
Phase 3(39)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (548)

Showing 20 of 548 trials
NCT07631156Phase 4Not Yet Recruiting

STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

Role: collaborator

NCT07572032Phase 4Recruiting

Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

Role: collaborator

NCT06388720Phase 2Recruiting

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Role: collaborator

NCT07613268Not ApplicableNot Yet Recruiting

Exploratory Trial of the "HiDongDong" Language Rehabilitation App for Articulation Delay.

Role: lead

NCT07062536Phase 2Not Yet Recruiting

mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

Role: lead

NCT05557123Not ApplicableCompleted

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

Role: lead

NCT05553314Phase 4Completed

Carvedilol in HF With Preserved EF

Role: lead

NCT07590843Completed

Efficacy and Safety of a Novel Monopolar Radiofrequency Device for Mid and Lower Face Rejuvenation

Role: lead

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT05365425Phase 4Recruiting

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Role: lead

NCT05365438Phase 4Recruiting

Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Role: lead

NCT03331718Phase 3Completed

PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial)

Role: collaborator

NCT06399835Phase 4Recruiting

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Role: lead

NCT06402747Phase 4Recruiting

Clopidogrel Versus Cilostazol on Vessels

Role: lead

NCT05076279Not ApplicableActive Not Recruiting

Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01)

Role: lead

NCT06622603Phase 4Recruiting

the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

Role: collaborator

NCT06870097Not ApplicableActive Not Recruiting

A Study on the Effects of A2 Milk on Gut Beneficial Bacteria Growth and Digestion Improvement

Role: lead

NCT06252636Not ApplicableActive Not Recruiting

Evaluation of the Efficacy and Safety of A2 Milk on Digestion

Role: lead

NCT05365412Recruiting

Clinicopathological Characteristics of Colon Cancer in Young Age

Role: lead

NCT04482478Not ApplicableRecruiting

Clinical Trial for the Evaluation of the Efficacy and Safety of EDL on Dyspepsia

Role: lead